Drugs /

bms-986340

Back to Drugs List

Overview

Clinical Trials

View Clinical Trials for bms-986340

Bms-986340 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating bms-986340, 1 is phase 1/phase 2 (1 open).

Microsatellite Stable (MSS) is the most frequent biomarker inclusion criterion for bms-986340 clinical trials.

Adenocarcinoma of the gastroesophageal junction, cervical carcinoma, and colorectal carcinoma are the most common diseases being investigated in bms-986340 clinical trials [2].

Top Biomarker Inclusion Criteria for Open Clinical Trials Investigating Bms-986340
This graph displays the 20 most frequently occurring biomarkers curated on clinical trials investigating bms-986340 and the cancer types associated with these biomarkers. These numbers are derived from a set of 5,956 clinical trials for which biomarker status defines treatment.

Drug Details

Synonyms [2]:
bms986340, bms 986340

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.